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Background: The dominant frequency of the Fourier power spectrum is useful to
analyze complex fractionated atrial electrograms (CFAE), but spectral resolution is
limited and uniform from DC to the Nyquist frequency. Herein the spectral resolution
of a recently described and relatively new spectral estimation technique is compared
to the Fourier radix-2 implementation.
Methods: In 10 paroxysmal and 10 persistent atrial fibrillation patients, 216 CFAE
were acquired from the pulmonary vein ostia and left atrial free wall (977 Hz
sampling rate, 8192 sample points, 8.4 s duration). With these parameter values, in
the physiologic range of 3–10 Hz, two frequency components can theoretically be
resolved at 0.24 Hz using Fourier analysis and at 0.10 Hz on average using the new
technique. For testing, two closely-spaced periodic components were synthesized
from two different CFAE recordings, and combined with two other CFAE recordings
magnified 2×, that served as interference signals. The ability to resolve synthesized
frequency components in the range 3–4 Hz, 4–5 Hz, . . ., 9–10 Hz was determined for
15 trials each (105 total).
Results: With the added interference, frequency resolution averaged 0.29 ± 0.22 Hz
for Fourier versus 0.16 ± 0.10 Hz for the new method (p< 0.001). The misalignment
error of spectral peaks versus actual values was ±0.023 Hz for Fourier and ±0.009 Hz
for the new method (p< 0.001). One or both synthesized peaks were lost in the
noise floor 13/105 times using Fourier versus 4/105 times using the new method.
Conclusions: Within the physiologically relevant frequency range for characterization
of CFAE, the new method has approximately twice the spectral resolution of Fourier
analysis, there is less error in estimating frequencies, and peaks appear more readily
above the noise floor. Theoretically, when interference is not present, to resolve
frequency components separated by 0.10 Hz using Fourier analysis would require an
18.2 s sequence duration, versus 8.4 s with the new method.
Keywords: Atrial fibrillation, Ensemble averaging, Fourier analysis, Spectral
estimation, Spectral resolutionIntroduction
Accurate spectral resolution is important for analysis of atrial fibrillation (AF) in the fre-
quency domain [1]. The information can be used, for example, to monitor periods of AF
versus sinus rhythm in patients with paroxysmal arrhythmia. For understanding the© 2012 Ciaccio et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Ciaccio et al. BioMedical Engineering OnLine 2012, 11:17 Page 2 of 15
http://www.biomedical-engineering-online.com/content/11/1/17mechanism by which the arrhythmia is maintained, it is also desirable to quantify any
temporal variation in frequency that can occur during AF [2]. Since frequency shifts can
be minute, sufficient resolving power is essential to detect these differences over short
time intervals. Yet this becomes more difficult when signal-to-noise ratio is low, as is often
the case. Another impediment to the generation of an accurate spectral profile is the pres-
ence of transients in the signal that are unrelated to physiologically relevant phenomena.
One way to improve continuity in the frequency domain representation of AF from one
instance of time to the next is to model and update the spectral profile based on new sig-
nal information as it is acquired in atrial fibrillation signals [2,3]. By using Gaussian func-
tions to model the spectral peaks, after leveling the spectral baseline, spurious or transient
changes to the signal frequency content can be excluded from the updates. When AF
organization is reduced, the harmonic pattern is also expected to diminish [2], while inde-
pendent spectral peaks caused for example by wavebreak can increase [4]. When resolving
power is insufficient, a broad spectral peak in the Fourier power spectrum may thus be in-
dicative of either a temporal variation in the frequency of a single component, or the mer-
ging of multi-component independent sources [5]. Therefore, the need for sufficient
spectral resolution is essential for AF analysis. Improved resolution could also be useful to
study the evolution and spontaneous termination of paroxysmal AF, as well as to estimate
the organization of atrial activity [6].
In recent work we introduced a paradigm for spectral estimation and signal transform-
ation of complex fractionated atrial electrograms (CFAE) based upon ensemble averaging
[7-9]. This relatively new technique, like Fourier analysis, depends upon the autocorrel-
ation function for generation of a power spectrum [9]. For spectral estimation, Fourier
analysis models the sinusoidal properties of the autocorrelation function, while the new
technique averages the autocorrelation function at lags w, 2w, 3w, . . ., where w is the
period [9]. The spectral resolution of Fourier analysis is constant across bandwidth, while
the spectral resolution of the ensemble average method depends inversely on w. The 1/w
relationship results in greater spectral resolution at lower frequencies, which includes the
electrophysiologic range of interest of ~ 3–10 Hz that is used for AF characterization.
Herein, the new technique is compared to Fourier analysis for discerning closely-spaced
frequency components in CFAE, which are of interest to characterize the arrhythmia and
to identify dominant frequencies.Method
Clinical data acquisition
Atrial electrograms were recorded in a series of 20 patients referred to the Columbia
University Medical Center cardiac electrophysiology (EP) laboratory for catheter ablation
of AF. These recordings were obtained prospectively as approved by the Internal Review
Board at Columbia University Medical Center, but were analyzed retrospectively after the
catheter ablation procedures were completed using standard clinical protocols. Ten
patients had documented clinical paroxysmal AF, and all 10 had normal sinus rhythm as
their baseline rhythm in the EP laboratory. AF was induced by burst atrial pacing from the
coronary sinus or right atrial lateral wall, and persisted for at least 10 minutes for those sig-
nals included in the retrospective analysis of this study. Ten other patients had longstand-
ing persistent AF, and had been in AF without interruption for 1–3 years prior to the
Ciaccio et al. BioMedical Engineering OnLine 2012, 11:17 Page 3 of 15
http://www.biomedical-engineering-online.com/content/11/1/17catheter mapping and ablation procedure. The surface electro gram signals were acquired
in analog form using the GE CardioLab system (GE Healthcare, Waukesha, WI) and fil-
tered from 30-500 Hz with a single-pole band pass filter to remove baseline drift and high
frequency noise. The filtered signals were digitally sampled by the system at 0.977 KHz and
stored. Although the band pass high end was slightly above the Nyquist frequency, negli-
gible signal energy is expected to reside in this frequency range [8].
Only signals identified as CFAEs by two cardiac electro physiologists were included in
the retrospective analysis. Candidate CFAE recordings of at least 10 seconds in duration
were obtained from two sites outside the ostia of each of the four pulmonary veins (PV).
Similar recordings were obtained at two sites on the endocardial surface of the left atrial
free wall, one in the mid-posterior wall, and another on the anterior ridge at the base of the
left atrial appendage. From each of these recordings, 8.4-second sequences (8192 sample
points) were analyzed. A total of 240 such sequences were acquired during electrophysiolo-
gic analysis – 120 from paroxysmal and 120 from longstanding AF patients. Subsequently,
only 216 of the recordings were determined to be CFAE, and only these were used for sub-
sequent analysis. As in previous studies, all CFAE signals were normalized to mean zero
and unity variance prior to further processing [9].
Frequency resolution
Using the radix-2 implementation for Fourier spectral estimation, the frequency reso-
lution is:
RF ¼ sample rate= discrete sample points
¼ 1=time duration ð1Þ
This resolution is uniform throughout the frequency range. Based upon the Nyquist the-orem, the range extends from DC to a maximum of ½ the sample rate. Atrial fibrillation
signals are typically acquired at 977 Hz digitization, as was done in this study. For evalu-
ation of the frequency content of CFAE, time durations of approximately 8 seconds are de-
sirable for analysis [10]. Using these parameter values, the resolution would be:
RF ¼ ð977 samples=sÞ=8192 samples ¼ 0:12 Hz ð2Þ
This frequency resolution is uniform throughout the range of DC to 977/2 = 489 Hz.
The total number of data points in the resulting power spectrum will be 8192/2 = 4096.
Thus the frequency resolution above the electrophysiologic range of interest, 10 Hz, to
the high limit of 489 Hz, is the same as the frequency resolution within the physiologic
range of 3–10 Hz.
A recently described technique that utilizes signal averaging was also used for spec-
tral estimation [7-9]. Briefly, an ensemble average vector ew with dimension w× 1 is
obtained by averaging the n successive mean zero segments of a signal x having dimen-
sion N× 1, with each segment being of length w:ew ¼ 1=n Uw x ð3aÞUw ¼ IwIw . . . Iw½  ð3bÞ
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matrix with dimension w×N, and Iw are w×w identity submatrices used to extract the
signal segments from x. The number of signal segments in the summation is:
n ¼ int N=wð Þ ð4Þ
where int is the integer function. If N/w is not an integer, then in forming Uw, 0’s are
added to the N – (n  w) columns at the matrices’ right edge [9]. The segment length w
can be converted to a frequency:
f ¼ sample rate=w ð5Þ
The power in the ensemble average is given by:
Pw ¼ 1=w ewT  ew ð6Þ






which has units of millivolts. The power spectrum can be displayed by plotting
√nPwRMS versus frequency f. The √n term levels the spectral baseline, which would
otherwise decrease by 1/√n, the noise falloff per number of summations n used for en-
semble averaging. Computer code to calculate this spectrum has been presented and
described elsewhere [9].
From Eq. 5, it is apparent that the frequency resolution of the new spectral estimation
technique is proportional to 1/w. This resolution can be calculated as:
RN ¼ SR=w½   SR= w þ 1ð Þ½  ¼ fw  fwþ1 ð8Þ
where RN is the resolution of the spectral estimator, SR is the sample rate, and fw and
fw+1 are any two adjacent points on its frequency spectrum. The frequency resolution
will be higher (i.e., the difference fw− fw+1 will be smaller) at points along the spectrum
where period w is longer (i.e. at low frequencies).
Akin to zero padding in Fourier analysis, it would be possible to interpolate between
discrete sample points and use real values of w to boost the number of spectral points
generated by the new method, but like padding for Fourier analysis, this would not add
information to the system. The integer values of w range from 2 to N/2, where the
upper bound of N/2 is given by the requirement that at least two signal segments are
needed to compute an ensemble average. The value at w= 1 is the DC level. Thus
analogous to the Fourier power spectrum, the power spectrum using the new technique
also has 4096 points of resolution. Yet, unlike Fourier analysis, this resolution is not
uniform. Based upon the 1/x relationship between frequency f and period w, the reso-
lution will be poor at high frequencies but excellent at low frequencies. This property
can be exploited for analysis of CFAE, since much of the frequency content of interest
is in the range 3–10 Hz [7,8]. In this range the average frequency resolution of the new
Ciaccio et al. BioMedical Engineering OnLine 2012, 11:17 Page 5 of 15
http://www.biomedical-engineering-online.com/content/11/1/17technique can be estimated from the resolution at representative frequency values. For
example the resolution at 3.5 Hz is given by:
RN;3:5Hz ¼ 977=w  977= w þ 1ð Þ
¼ 977=279 977=280 ¼ 3:502 Hz 3:489 Hz ¼ 0:013 Hz ð9Þ
Similarly, the resolution at 4.5 Hz is:
RN;4:5Hz ¼ 977=w  977= w þ 1ð Þ
¼ 977=217 977=218 ¼ 4:502 Hz 4:481 Hz ¼ 0:021 Hz ð10Þ
The average resolution as determined from the resolution at 3.5, 4.5, 5.5,. . ., 9.5 Hz is
0.05 Hz. However to resolve two peaks, there must be at least one point of power spectral
resolution separating them. Thus the minimum frequency at which two spectral peaks can
be resolved would be 2×0.12 Hz=0.24 Hz for Fourier, and on the average
2×0.05 Hz=0.10 Hz for the new method in the range 3–10 Hz (see second column,
Table 1). As a note of comparison, to theoretically resolve frequency components separated
by 0.10 Hz using Fourier analysis would therefore require an 18.2 s sequence duration, ver-
sus 8.4 s with the new method.
Synthesis of simulated CFAE and power spectra
CFAE with closely-spaced frequency components were artificially synthesized to test the
resolution of the methods as follows. First a sequence of random length ω was extracted
from one of the 216 CFAE recordings, which was also selected at random. The extracted
sequence of length ω was repeated to N=8192 sample points to form one signal compo-
nent. Then another random sequence, with length ω+2, was extracted from another ran-
domly selected CFAE recording. The extracted sequence of length ω+2 was also repeated
to N=8192 sample points to form a second signal component. Two other of the 216
CFAE recordings selected at random were each amplified with a gain of ×2 to be used as
interference as in a previous study [8]. Thus the following four randomly obtained
sequences of length 8192 sample points were summed and used for subsequent analysis:
1. signal component 1 with repeating period w
2. signal component 2 with repeating period w+ 2
3. interference 1 with 2× gain
4. interference 2 with 2× gainTable 1 Resolution to discern closely-spaced frequency components
Freq. (Hz) Res-theor (Hz) Res-NT (Hz) Res-FT (Hz) Significance
9.37 ± 0.47 0.19 0.21 ± 0.05 0.25 ± 0.08 P = 0.307
8.49 ± 0.24 0.15 0.23 ± 0.09 0.28 ± 0.08 P = 0.105
7.51 ± 0.32 0.11 0.18 ± 0.07 0.29 ± 0.18 P = 0.081
6.47 ± 0.27 0.09 0.14 ± 0.04 0.32 ± 0.20 P = 0.003
5.45 ± 0.32 0.06 0.13 ± 0.09 0.27 ± 0.18 P < 0.001
4.37 ± 0.27 0.04 0.08 ± 0.03 0.22 ± 0.07 P < 0.001
3.51 ± 0.29 0.03 0.07 ± 0.04 0.19 ± 0.06 P < 0.001
6.41 ± 2.01 (MN) 0.10 0.16 ± 0.10 (MN) 0.29 ± 0.22 (MN) P < 0.001
Freq.: the mean frequency used for the test, Res-theor – the theoretical resolving power of the new method, Res – NT:
the resolving power of the new method, Res – FT: the resolving power of Fourier analysis, Significance – the significance
of the difference between the resolving power of the techniques based on the unpaired t-test. MN – mean value.
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end of the spectral range. Repeating segments with ω=180 sample points and ω+2=182
sample points are shown in panels A and B, respectively (f = 5.43 Hz and 5.37 Hz). The
sum of two additive interferences with a gain of 2× is shown in panel C. The result from
combining the components of panels A, B, and C is shown in panel D. The original peri-
odicities are mostly unrecognizable in panel D. Similarly, an example for components with
frequencies toward the high end of the electrophysiologic range of interest is shown in
Figure 2. Repeating segments with ω=113 sample points and ω+2=115 sample points are
shown in panels A and B, respectively (f = 8.65 Hz and 8.50 Hz). Additive interferences are
shown in panel C. The result from combining the components of panels A, B, and C is
shown in panel D. The original periodicities are again mostly unrecognizable.
This paradigm was repeated so that a total of 15 simulated CFAE with closely-spaced fre-
quency components in the range 3–4 Hz, 15 in the range 4–5 Hz, . . ., and 15 in the range
9–10 Hz were constructed. Thus the total number of simulation signals to be analyzed, of
the type shown in Figure 1D and 2D, was 7×15=105.
Prior to Fourier analysis, each simulated signal was zero-padded to a length N=65536,
for a final interval of 0.015 Hz between spectral points. By zero padding, the frequency
resolution of the FFT was not increased, only the point-to-point interval in the resulting
spectrum, because the length of the observed signal was unchanged. Zero padding ensured
that closely-spaced spectral components would be evident within the limit given by the fre-
quency resolution constraint. The Fourier power spectrum was generated using a radix-2
implementation [11]. Initially the simulated CFAE were preprocessed with a Han window
prior to Fourier analysis. However, while Han windowing can improve periodicity by for-
cing the signal ends to zero, it also adds distortion in the form of amplitude modulation.
The amplitude modulation can impart spectral sidebands which reduce frequencyFigure 1 Example of synthesized signals at the low range in frequency. A-B. Synthesized
frequency components. C. Interferences. D. Combination of synthesized frequency components and
interferences.
Figure 2 Example of synthesized signals at the high range in frequency. A-B. Synthesized
frequency components. C. Interferences. D. Combination of synthesized frequency components and
interferences.
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ponents was improved without this filter. Therefore a rectangular window (i.e. no filter)
was used for Fourier analysis. Likewise, no window preprocessing was done prior to spec-
tral estimation with the new method.
Consider the spectral profiles of both Fourier and new technique, each of which consists
of 4096 data points for parameter values of 977 Hz sample rate and a signal length of 8192
sample points. As shown in Figures 1 and 2, the initially synthesized signals had frequency
components of ω and ω+ γ, where γ=2, the minimum resolving distance. To determine
the ability of each method to resolve closely-spaced peaks, γ was increased by 1 in each of
the simulated signals until two distinct peaks appeared in the spectrum. Closely-spaced
synthesized frequency components were considered to be resolved for the minimum value
of γ for which any resulting spectral peaks with periods w and w+α met the following four
criteria. The first requirement for discernability was that:
s2 > s1=4 ð11Þ
where s is the amplitude of the tallest spectral peak in proximity to the actual location of a
synthesized frequency component, referenced to that foot which gives the largest peak
amplitude, s1 is the amplitude of the higher peak, and s2 is the amplitude of the lower peak.
An example of peak amplitude measurement is shown in Figure 3B (solid vertical arrows).
The second requirement for discernability is that the minimum value between the two
peaks:
smin¼ min swþ1 : swþα1½  ð12Þ
is within or below the maximum range b of the neighboring background level (Figure 3B).
The neighboring background level is defined as the range in magnitude −0.25 Hz in
Figure 3 Examples of frequency spectra used for analysis for CFAE with two closely-spaced
frequency components at the low end of range. A. The power spectrum using the new technique in
the range 1–12 Hz. B. A close-up of the power spectrum with a range of 2 Hz. The parameters used to
determine whether the synthetic frequency components are resolved are shown. C. The Fourier power
spectrum in the range 1–12 Hz. D. A close-up of the Fourier power spectrum with a range of 2 Hz. The
synthetic frequency components are not resolved in the Fourier spectrum.
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right foot of peak w (horizontal lines, Figure 3B). The third criterion is that:
sw; swþα > b ð13Þ
that is, the magnitudes sw and sw+α are greater than the maximum range b of the neighbor-
ing background level (Figure 3B). The final criterion is that the peaks at w and w+α are
each within ±0.15 Hz of the two synthesized frequency components having actual periods
of ω and ω+ γ (noted with bars at the top of the graph in Figure 3B).
The spectral resolution of Fourier analysis versus the new technique in the presence of
interference were determined as follows. The criteria as given by Equations 11, 12 and 13
were tested for two synthesized spectral components with periods ω and ω+ γ, γ=2
through 20 spectral points. Again, the lower limit of 2 was necessitated by the fact that
two frequency components occurring at adjacent spectral points (γ=1) cannot be
resolved. The minimum value of γ for which these criteria were met was defined as the
spectral resolution to discern the closely-spaced simulated spectral peaks. If these criteria
were not met to γ=20, the trial was tabulated as being one in which the resolution was in-
determinable due to the loss of one or more spectral peaks in the noise floor. For both
methods, the estimate error was defined as the average of the absolute difference in fw - fω
and fw+α – fω+γ, where fw and fω are the measured and actual frequencies of one of the
peaks, and fw+α and fω+γ are the measured and actual frequencies of the other peak, re-
spectively. For Fourier analysis, a correction was made by subtracting 0.06 Hz from each
error after calculating the absolute difference of measured to actual frequency, with the
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city, the synthetic frequencies that were used were always 1/w, with w being an integer, so
that on average for Fourier analysis, having constant increments of 0.12 Hz between spec-
tral points, the actual frequency components could be different by as much as ±0.06 Hz.
For the new technique, the spectral points occurred at 1/w for all w in range, so no cor-
rection was done.
The overall paradigm was repeated for 15 trials in each frequency range 3–4 Hz, 4–5 Hz,
. . ., 9–10 Hz for both Fourier analysis and the new technique. The results were averaged
and tabulated as mean± standard deviation. The unpaired t-test was used to determine the
significance of the difference between methods (SigmaPlot 2004 for Windows Ver. 9.01,
Systat Software, Chicago, and MedCalc ver. 9.5, 2008, MedCalc Software bvba, Mariakerke,
Belgium).Results
Spectral properties
A power spectrum using the new spectral estimation technique is shown in Figure 3A.
Note that the highest frequency resolution occurs at lower frequencies due to the 1/w re-
lationship of resolution to frequency for this method. By comparison, the Fourier power
spectrum is uniform in resolution across the range (Figure 3C). Figures 3B and D show
close-ups of the respective spectra in the range of the synthesized components. The actual
synthesized components have frequencies of 5.34 Hz (ω+ γ=183 sample points at 977 Hz
sampling rate) and 5.43 Hz (ω=180 sample points), noted by vertical bars at the tops of
panels 3B and 3D. The two components are correctly resolved by the new technique
(panel 3B), that is, w=ω and w+/=ω+ γ. However, Fourier analysis does not resolve at
this component spacing (panel 3D). In Figure 4, using the same CFAE and with the high
frequency remaining at 5.43 Hz (ω=180 sample points), the result is shown for γ=19
when the low frequency is 4.91 Hz (ω+ γ=199 sample points). The spectrum and close-
up using the new method are shown in Figure 4A-B, and the frequency components are
readily resolved as in Figure 3A-B. The Fourier spectrum is shown in Figure 4C-D and
now distinct peaks appear (Figure 4D), meeting the criteria set forth in the Methods. This
was the minimum distance γ at which two corresponding Fourier spectral peaks met the
criteria, and therefore the resolution for the Fourier spectrum. The measurements for
sw+α, sw, smin, and b are shown.
The power spectrum from 1–12 Hz using the new technique with a different set of sig-
nals, and synthesized components near the higher end of the frequency range is shown in
Figure 5A. The components reside at fω+γ=8.50 Hz and fω=8.65 Hz. Several subharmonics
present in the range 1–4 Hz are evident in Figure 5A. The Fourier power spectrum from
the same synthesized signal is shown in the range 1–12 Hz in Figure 5C. There are sub-
stantial superharmonics in the high frequency range from 9.5–12 Hz. Close-ups are shown
in the right-hand panels for both methods. Even though the spectral resolution for the new
technique is diminished in this frequency range, it resolves the peaks when γ=2
(Figure 5B). The parameters used for measurement are shown in this panel. The Fourier
power spectrum does not resolve at this level (panel 5D). There is only a single blunted
peak from about 8.5 Hz to 8.75 Hz. The same data is shown for γ=4 in Figure 6. The fre-
quency components remain involved for the new method (Figure 6B) and first resolve for
Figure 4 Same data as in Figure 3 except that the synthetic frequency components are spaced
further apart (γ is larger). The panels correspond to those in Figure 3. B. The synthetic frequency
components remain resolved using the new technique. D. The synthetic frequency components resolve
using Fourier analysis.
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fω+γ=8.35 Hz and fω=8.65 Hz. The parameters indicating that the Fourier spectral peaks
resolve are noted (Figure 6D).
Summary statistics
For a total of 105 trials, excluding those in which the synthesized components could not be
resolved, the mean frequency resolution with the presence of additive interference was
0.29±0.22 Hz for Fourier and 0.16±0.10 Hz for the new technique (p<0.001). Thus the re-
solving power of each method, in the presence of interference, was similar to their respect-
ive theoretical resolutions of 0.10 Hz and 0.24 Hz. A complete summary of the resolving
power of both techniques is provided in Table 1. The mean frequency for the random trials
in each frequency bin that resolved are shown in the rows of column 1 from top to bottom
(9–10 Hz, 8–9 Hz, . . .). The expected resolution at 9.5 Hz, 8.5 Hz, . . ., using the new
method, are noted in the second column. The actual resolving power for the new technique
and for the Fourier transform are shown in the next two columns, respectively. At all fre-
quencies, the new technique resolving power is improved over the Fourier method. The sig-
nificance of the difference in mean resolving power between the methods is noted in the
right-hand column. At lower frequencies up to 7 Hz there is a highly significant difference
(p≤0.003). At higher frequencies the difference trends toward significance.
The average of the absolute misalignment of spectral peaks with actual values of
synthesized components (the estimate error) was 0.023 ± 0.039 Hz for Fourier and
0.009 ± 0.030 Hz for the new technique (p < 0.001). A complete summary of the esti-
mate error for both methods is provided in Table 2. The mean frequency for the trials
Figure 5 Examples of frequency spectra used for analysis for CFAE with two closely-spaced
frequency components at the high end of range. Panels correspond to those in Figure 3. The synthetic
frequency components reside at approximately 8.5 Hz, and are resolved by the new technique (panel
B). Measurement parameters are shown. The synthetic frequency components are not resolved by
Fourier analysis (panel D).
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bottom, as in Table 1. The estimate error values for each frequency bin are shown for
the new technique and for Fourier analysis in the middle columns. In each case, the
error, or misalignment of spectral peak with respect to actual component frequencies,
is substantially less using the new technique. The significance of the difference in error
between the new technique and Fourier analysis is noted in the right-hand column.
There is a high degree of significance at all frequencies except the 9–10 Hz bin.
Overall, of 15 trials for each frequency bin (105 trials in all), one or both frequency
components did not appear above the noise floor in 13/105 trials using the Fourier
method (12.4%) versus 4/105 trials using the new technique (3.8%).
Discussion
Summary
In this study a comparison was made between the ability to resolve two closely-spaced fre-
quency components in the physiologic range of interest using Fourier power spectral ana-
lysis, versus a new technique that utilizes signal averaging. The synthesized closely-spaced
frequency components and two additive interferences were selected at random from a set
of 216 CFAE. The values for digital sampling rate (977 Hz) and sequence length (N=8192,
8.4 s sequences) are typical of those used for frequency analysis of CFAE obtained during
clinical EP study. Tests were made in the range 3–10 Hz, the electrophysiologic range for
evaluation of atrial electrical activity. From 105 tests, the mean resolving power of Fourier
versus the new technique (0.29 Hz versus 0.16 Hz; p<0.001), were higher than the theoret-
ical values but in accord with the presence of large interferences that could act to mask the
Figure 6 Same data as in Figure 5 except that the synthetic frequency components are spaced
further apart. The panels correspond to those in Figure 3. The synthetic frequency components remain
resolved using the new technique in panel B. The synthetic frequency components resolve using
Fourier analysis in panel D.
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Fourier power spectrum. By comparison, this occurred in only 4/105 trials using the new
technique. The error in estimating the synthesized components was ±0.023 Hz using Fou-
rier versus ±0.009 Hz using the new technique (p<0.001).
Signal segment not used for spectral estimation
Based upon Eq. 4, whenever n is not an integer, a portion of the 8.4 second CFAE sig-
nal at its end is not used for spectral estimation. This can be described as:
L ¼ N=w  int N=wð Þ½ =977 ð14Þ
where L is the unused signal segment length in seconds. In Figure 7 is shown a plot of
segment length versus frequency in the physiologic range of interest (3–10 Hz). TheTable 2 Estimate error in the frequency of peak values
Freq. (Hz) Error NT (Hz) Error FT (Hz) Significance
9.37 ± 0.47 0.032 ± 0.074 0.039± 0.070 P = 0.708
8.49 ± 0.24 0.004 ± 0.003 0.016± 0.015 P < 0.001
7.51 ± 0.32 0.004 ± 0.002 0.027± 0.043 P = 0.006
6.47 ± 0.27 0.005 ± 0.007 0.017± 0.023 P = 0.011
5.45 ± 0.32 0.003 ± 0.002 0.018± 0.023 P = 0.001
4.37 ± 0.27 0.003 ± 0.002 0.019± 0.019 P < 0.001
3.51 ± 0.29 0.013 ± 0.035 0.043± 0.053 P = 0.016
6.41 ± 2.01 (MN) 0.009 ± 0.030 (MN) 0.023± 0.039 (MN) P < 0.001
Freq.: the mean frequency used for the test, Error – NT: the difference between the actual and estimated frequency using
the new method, Error – FT: the absolute difference between actual and estimated frequency using Fourier analysis,
Significance – the significance of the difference between the techniques based on the unpaired t-test. MN – mean value.
Figure 7 Plot of the segment length at the end of the each CFAE signal that is unused for each
power spectrum calculation using the new technique, versus frequency in the physiologic range.
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http://www.biomedical-engineering-online.com/content/11/1/17maximum unused segment length, 0.3 seconds, occurs at 3.1 Hz, near the lowest fre-
quency in the range. The mean unused segment length is approximately 0.1 seconds.
Thus on the average, 8.3 seconds of the 8.4 second signal is used for power spectral es-
timation, meaning that only about 1% of the signal is not included in the measurement.Clinical correlates
The dynamics of internal fibrillatory activity are of great interest to establish AF
mechanisms as well as for catheter ablation, and can be measured using markers of
organization [12]. It would be desirable to correlate these invasive measurements with
noninvasive electrocardiogram measurements, to determine the extent to which AF
can be characterized noninvasively with for example, a Holter monitor [12]. It is also
desirable to distinguish slightly different levels of organization during AF by improving
temporal resolution and sensitivity [13]. Such improvements could lead to new ways of
analyzing and understanding AF, and improved AF treatment methods [13]. The para-
meters used in our study for analysis of CFAE are typical for clinical investigations. The
capability of the Fourier transform to resolve two independent frequency components
in close proximity, 0.24 Hz, is unacceptable for describing the temporal evolution of
paroxysmal AF or to differentiate this type from persistent AF. Using Fourier analysis,
the dominant frequency, defined as the tallest spectral peak in the physiologic range of
interest, often varies with a standard deviation of 0.2–0.3 Hz when CFAE are recorded
from each of the four pulmonary vein ostia [14]. Thus the resolving power using the
Fourier spectrum is likely to be insufficient for detailed, accurate measurement. To de-
termine whether differences in the frequencies of spectral peaks are real or artifact
requires an increase in resolving power, as is possible with our new technique. Further-
more, the ability to resolve multiple characteristic frequencies in AF signals, which may
be caused by multiple wavelets propagation as are commonly found in AF data, is more
difficult when the electrical activity is highly unorganized [15]. Applying the new tech-
nique to these signals can potentially increase the ability to spectrally resolve the mul-
tiple activation wavelets that can be present in the arrhythmogenic substrate.
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In this study we demonstrated that the resolving power to discern two closely-spaced synthe-
sized frequency components was significantly greater using a new spectral estimation tech-
nique as compared with Fourier analysis. Furthermore, the new technique estimates the
actual frequencies of the components to a significantly greater degree of accuracy as com-
pared with Fourier. The simulations suggest that two closely-spaced frequency components,
as might be encountered by drivers of electrical activation in close spatial proximity to one
another within the arrhythmogenic substrate that is causing atrial fibrillation, can be dis-
cerned by the new technique, even in combination with substantial interference levels. Such
interferences may represent, for example, independent drivers at the periphery of the sub-
strate that are inconsequential to the maintenance of AF. Thus this method may be helpful
to detect and identify independent drivers in the atrial substrate that can be masked by inter-
ference from bystander regions. Such information is potentially important to develop a mech-
anistic understanding of the pattern of electrical activation during atrial fibrillation. Although
only CFAE simulations were done in this study, these observations are probably applicable to
other types of signals including ventricular electrograms [16] and electrocardiogram data
[17]. Furthermore, better spectral resolution can be important for improved recognition of
repeating patterns in CFAE when analyzed in the frequency domain [18].Limitations
For simplicity, the number of trials for discerning closely-spaced frequency components was
limited to 15 for each of seven frequency bins in the electrophysiologic range of interest.
The types of interference signals and the types of periodic components that were used were
limited to those present in a pool of 216 CFAE recordings obtained from the pulmonary
vein ostia and left atrial free wall in both paroxysmal and longstanding AF patients. The use
of synthesized components was necessitated by the fact that frequency values needed to be
known with certainty. Since synthesized signals were tested, they will not necessarily repre-
sent the performance of Fourier spectral analysis versus the new technique on real data. Still,
since the synthesized frequency components and interferences were extracted from real
CFAE, we believe that they are representative of the types of signals that would be encoun-
tered in real measured data.
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